Clinical trial: Add-on treatment for high cholesterol
This is a study to determine whether treatment with a new drug (lapaquistat acetate) reduces bad cholesterol levels when given with ongoing statin treatment. This national study is currently recruiting patients.
(National Institutes of Health) UPDATED 08/04/2008Click here to read the full story

